Funds holding Perspective Therapeutics Inc
107 funds declare a position · 19 ETFs and 88 other funds · 60.2M $ · US46489V3024
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 101 | Russell 2000 Fund Rydex Series Funds | 140 | 583.8 $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 102 | SMALL-CAP PROFUND ProFunds | 113 | 440.7 $ | 0.01 % | as of Apr 30, 2026 · Original filing |
| 103 | Russell 2000 1.5x Strategy Fund Rydex Series Funds | 84 | 350.3 $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 104 | ProShares Hedge Replication ETF ProShares Trust | 61 | 329.4 $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 105 | Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 60 | 250.2 $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 106 | ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 17 | 91.8 $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 107 | Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 16 | 66.7 $ | 0.00 % | as of Mar 31, 2026 · Original filing |
Institutional managers
131 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| TCG Crossover Management, LLC | 7,915,567 | 33M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 6,336,782 | 26.4M $ | as of Mar 31, 2026 |
| Avidity Partners Management LP | 6,049,999 | 25.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,348,561 | 22.3M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 4,675,000 | 19.5M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 4,046,640 | 16.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 3,566,504 | 14.9M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 3,164,582 | 13.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,132,670 | 13.1M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 2,994,460 | 12.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,983,342 | 12.4M $ | as of Mar 31, 2026 |
| Spruce Street Capital LP | 2,627,107 | 11M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,766,960 | 7.4M $ | as of Mar 31, 2026 |
| Patient Square Capital LP | 1,625,000 | 6.8M $ | as of Mar 31, 2026 |
| Nicholson Wealth Management Group, LLC | 1,618,993 | 6.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,241,816 | 5.2M $ | as of Mar 31, 2026 |
| Yu Fan | 1,055,409 | 4.4M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,003,474 | 4.2M $ | as of Mar 31, 2026 |
| Ally Bridge Group (NY) LLC | 926,557 | 3.9M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 910,221 | 3.8M $ | as of Mar 31, 2026 |
| Hills Bank & Trust Co | 872,200 | 3.6M $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 791,555 | 3.3M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 749,335 | 3.1M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 661,318 | 2.8M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 528,928 | 2.2M $ | as of Mar 31, 2026 |